temporomandibular disorders. Temporomandibular joint disorder, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Laser therapy with LUMIX 2 HFPL low power diode laser machine made in Italy with wavelength nm810, output power mw500 and energy density j/cm2 21, frequency 13 kHz,
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with a history of pain with VAS=4 in masticatory muscles and/or temporomandibular joint during jaw movements or function (TMD muscle disorders (Class Ia, Ib) or anterior displacement of the disc with or without return (Class IIa, IIb) or arthralgia ( Class IIIa) based on (RDC/TMD) Limitations in jaw movements (mouth opening < 40 mm or side movements < 8 mm) Jaw sound while opening and closing the mouth Deviation during opening and closing the mouth
Exclusion criteria
Exclusion criteria: Patients with a history of acute trauma Patients who have been treated for temporomandibular joint disorders in the last month Any pain with other origins such as decayed teeth, impacted teeth, other pathological lesions or neurological disorders in the head and neck area People with congenital and neoplastic diseases in the TMJ range People with joint diseases such as osteoarthritis and rheumatoid arthritis or suffering from hypermobility syndrome Uncontrolled systemic problems with disability (ASA II or higher) including diabetes, thyroid disease, kidney disease, epilepsy and people with cerebrovascular problems People with bleeding diseases or users of anticoagulants Users of corticosteroid drugs Cardiac patients or those with a pacemaker Pregnant or breastfeeding mothers Patients with psychiatric disorders such as severe depression and psychosis Patients with any severe orthognathic deformities Patients with posterior edentulousness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: The beginning and end of the study and One month after the last treatment session. Method of measurement: questionnaire.;Maximum mouth opening. Timepoint: The beginning and end of the study and One month after the last treatment session. Method of measurement: Ruler with millimeter division.;Pain. Timepoint: The beginning and end of the study and One month after the last treatment session. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRasool Bagheri
Semnan University of Medical Sciences
Outcome results
None listed